(Press-News.org) SAN FRANCISCO—- Testosterone therapy is associated with decreased pain perception in men with low testosterone levels related to
opioid (narcotic) pain relievers (analgesics), a new study finds. The results were presented Monday at The Endocrine Society's 95th
Annual Meeting in San Francisco.
"In this study, we attempted to determine whether testosterone replacement improves pain perception and tolerance, and quality of
life in men with low testosterone levels due to narcotic analgesics," said the study's lead author Shehzad Basaria, MD, Medical Director,
Section of Men's Health, Aging, & Metabolism at Brigham & Women's Hospital, Harvard Medical School, in Boston, MA. "We found that
testosterone administration in these men was associated with a greater reduction in several measures of pain sensitivity during laboratory
pain testing compared with men who were on placebo."
Opioids belong to a class of pain-reducing drugs that are used to relieve chronic pain from injuries, surgery and cancer treatment.
These drugs include morphine, codeine, fentanyl and oxycodone, and are among the most frequently prescribed medications in the United States
today.
In addition to being highly addictive, opioid use is associated with a number of side effects, including suppression of the
hypothalamic-pituitary-gonadal axis in both women and men, resulting in decreased testosterone production. Low testosterone, in turn, can
result in sexual dysfunction, decreased muscle mass, increased fat mass and decreased quality of life.
Previous animal research has demonstrated that castration of rodents is associated with increased pain perception while testosterone
replacement reduces pain perception, suggesting an analgesic effect of this sex steroid. Whether these beneficial effects can be replicated
in humans, however, remained unclear.
In this study, investigators found that, compared to placebo, testosterone therapy significantly improved pain perception and tolerance
during laboratory pain testing. Testosterone therapy also improved some aspects of quality of life.
"If larger studies confirm these findings, testosterone therapy in this patient population may be beneficial in improving pain perception,"
Basaria said.
The study included 84 men ages 18-64 years old with opioid-induced testosterone deficiency. Their average age was 49 years. Of this group,
65 participants completed the study. Investigators randomly assigned participants to receive either testosterone gel, applied to the skin, or
placebo, for 14 weeks. Thirty-six men received the testosterone gel, and 29 received a placebo.
At the beginning of the study, and then again at 14 weeks, the investigators assessed pain measures and quality-of-life parameters.
Solvay (now Abbott) Pharmaceuticals, Inc. funded the study.
###
Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones
and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians,
educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology.
The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at
http://www.endocrine.org. Follow us on Twitter.
Testosterone therapy may help improve pain in men with low testosterone
2013-06-18
ELSE PRESS RELEASES FROM THIS DATE:
Investigational drug improves sleep disorder among the blind
2013-06-18
SAN FRANCISCO—- An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday at The Endocrine Society's Annual Meeting in San Francisco.
The new drug, called tasimelteon, selectively targets the master body clock in the brain, which controls the timing of the sleep-wake cycle, alertness patterns and the timing of some hormones, as well as many other aspects of physiology and metabolism. This study found that ...
Testosterone improves verbal learning and memory in postmenopausal women
2013-06-18
SAN FRANCISCO—- Postmenopausal women had better improvement in verbal learning and memory after receiving treatment with testosterone gel, compared with women who received sham treatment with a placebo, a new study found. Results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"This is the first large, placebo-controlled study of the effects of testosterone on mental skills in postmenopausal women who are not on estrogen therapy," said principal investigator Susan Davis, MBBS (MD), PhD, of Monash University, Melbourne, Australia. ...
High-fat diet during pregnancy contributes to offspring's increased weight
2013-06-18
SAN FRANCISCO-- Exposure to a high-fat diet in the womb and after birth can permanently change the cells in the brain that control food intake, predisposing monkeys to overeating and an increased preference for fatty and sugary foods, a new study finds. The results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The study, funded by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases, also found that male offspring of maternal monkeys that ate a high-fat diet had increased body weight, ...
Naturally occurring hormone induces egg maturation
2013-06-18
SAN FRANCISCO-- The naturally occurring hormone kisspeptin effectively induces egg maturation during infertility treatment, according to a clinical in vitro fertilization (IVF) study. The results were presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Aptly named after the popular chocolate Hershey's kiss candy, kisspeptin was discovered in Hershey, PA, in 1996. Released by the brain in both males and females, the hormone triggers the development of secondary sexual characteristics and other changes of puberty.
Each year, thousands of ...
New way to improve antibiotic production
2013-06-18
An antibiotic has been found to stimulate its own production. The findings, to be published in PNAS, could make it easier to scale up antibiotic production for commercialisation.
Scientists Dr Emma Sherwood and Professor Mervyn Bibb from the John Innes Centre were able to use their discovery of how the antibiotic is naturally produced to markedly increase the level of production.
"We have shown for the first time that an antibiotic with clinical potential can act as signalling molecule to trigger its own synthesis," said Professor Bibb.
The antibiotic called planosporicin ...
Pesticides significantly reduce biodiversity in aquatic environments
2013-06-18
This news release is available in German. Washington/Leipzig/Sydney. The pesticides, many of which are currently used in Europe and Australia, are responsible for reducing the regional diversity of invertebrates in streams and rivers by up to 42 percent, researchers report in the Proceedings of the US Academy of Sciences (PNAS). Mikhail A. Beketov and Matthias Liess from the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, together with Ben Kefford from the University of Technology, Sydney and Ralf B. Schäfer from the Institute for Environmental Sciences ...
New medication treats drug-resistant prostate cancer in the laboratory
2013-06-18
A new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"Our novel prostate cancer drug works by a unique mechanism of action," said study lead author Jeremy Jones, PhD, assistant professor of molecular pharmacology at City of Hope, Beckman Research Institute, in Duarte, CA. "Thus, it has the potential to treat cancers resistant to currently approved therapies."
Prostate ...
Obesity leads to brain inflammation, and low testosterone makes it worse
2013-06-18
Low testosterone worsens the harmful effects of obesity in the nervous system, a new study in mice finds. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"Low testosterone and obesity are common in aging men, and each is associated with type 2 diabetes and Alzheimer's disease," said the study's lead investigator, Anusha Jayaraman, PhD, of the University of Southern California in Los Angeles. "Our new findings demonstrate that obesity and low testosterone combine to not only increase the risk of diabetes but also damage ...
Directed in vitro technique may increase insulin resistance among offspring
2013-06-18
A special type of in vitro fertilization, or IVF, may increase the risk for insulin resistance among children conceived in this way, according to a new study from Greece. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
During natural fertilization, as well as other IVF treatments, the egg is exposed to many sperm. In both of these cases, the strongest, healthiest sperm has the best chance of reaching and fertilizing the egg.
In contrast, the type of assisted reproductive technology, or ART, examined in this study ...
Missing enzyme linked to drug addiction
2013-06-18
A missing brain enzyme increases concentrations of a protein related to pain-killer addiction, according to an animal study. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Opioids are pain-killing drugs, derived from the opium plant, which block signals of pain between nerves in the body. They are manufactured in prescription medications like morphine and codeine, and also are found in some illegal drugs, like heroin. Both legal and illegal opioids can be highly addictive.
In addition to the synthetic opioids, natural ...